Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up

Chemotherapy in light chain amyloidosis aims to normalize the involved free light chain in serum, which leads to an improvement, or at least stabilization of organ function in most responding patients. We performed a prospective single center phase 2 trial with 50 untreated patients not eligible for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegenbart, Ute, Bochtler, Tilmann, Benner, Axel, Becker, Natalia, Kimmich, Christoph, Kristen, Arnt V., Beimler, Jörg, Hund, Ernst, Zorn, Markus, Freiberger, Anja, Gawlik, Marianne, Goldschmidt, Hartmut, Hose, Dirk, Jauch, Anna, Ho, Anthony D., Schönland, Stefan O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541875/
https://www.ncbi.nlm.nih.gov/pubmed/28522573
http://dx.doi.org/10.3324/haematol.2016.163246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541875/
https://www.ncbi.nlm.nih.gov/pubmed/28522573
http://dx.doi.org/10.3324/haematol.2016.163246

Ejemplares similares